Opus IRB

March 21, 2011 08:30 ET

Opus IRB Adds Senior Management Talent

Judy Cherry Brings Extensive Experience With Clinical Research

ATLANTA, GA--(Marketwire - March 21, 2011) - Opus IRB, a central institutional review board focused on safeguarding the rights and welfare of human research participants, has added Judy Cherry, RN, CCRC, to its team of highly experienced professionals. Cherry will serve as Administrative Director, overseeing operations and serving as a liaison between the IRB, research sponsors and research sites.

Prior to joining Opus IRB, Cherry amassed over 20 years of clinical research experience and most recently served as corporate director of the Piedmont Healthcare Research Institute. She has held several other positions over her career including director of cardiovascular research at the Fuqua Heart Center and director of the Bone Marrow & Stem Cell Transplant Center Clinical Research Program at Emory University.

Cherry is a Registered Nurse and Certified Clinical Research Coordinator (from the Association of Clinical Research Professionals). She is a listed author for almost two dozen peer-reviewed scientific papers.

"My goal is to focus on making our program one of the industry leaders," said Cherry. "I've worked in virtually every area of clinical trials, but my passion is the protection of human research participants."

The Opus IRB team is comprised of individuals from all areas of research including the pharmaceutical and medical device industries, private and public hospitals/universities, clinical research clinics/sites and clinical research auditing and compliance.

"Opus IRB is adding a great new talent to our team with Judy Cherry. Judy brings a wealth of experience and knowledge in all aspects of clinical research. We are very excited that she is joining our team, and look forward to the limitless possibilities with Judy at the helm," Donald Johnson, Chief Operations Officer, Opus IRB.

The company offers a single point of contact for sponsors while assisting institutional IRBs, which often are overburdened and have limited resources.

The first priority of Opus IRB is to ensure the protection of human subjects, which is why a compliance officer and internal audit review are parts of Opus IRB that are of the utmost importance. The founders have acted as IRB chairpersons, IRB board members, principal investigators, site administrators and site auditors, and have over 50 years of combined clinical research experience.

The Opus Board is equally qualified and is comprised of individuals throughout the United States, providing a uniquely national research perspective and expertise.

About Opus IRB
Opus IRB is a central institutional review board focused on safeguarding the rights and welfare of human research participants. Opus bridges the gap between human research participants, investigators and research sponsors.

Contact Information